Latest Investments News

Emerald Resources NL has reported a substantial increase in gold mineral resources at its Memot and Dingo Range projects, advancing its goal to become a multi-mine gold producer.

Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.

Paladin Energy reported a $18.4 million operating cash outflow in Q2 2025 but maintains a strong liquidity position with $89 million in cash and $139 million in total available funding.

Astron Corporation has released updated economics for its Donald Rare Earth and Mineral Sands Project, showcasing robust financial metrics and targeting a Final Investment Decision by late 2025 with production slated for 2027.

Westgold Resources capped FY25 with record quarterly gold production and a $132 million treasury boost, while announcing a maiden 2.3 million ounce resource at its Fletcher Zone.

Mitchell Services Limited reported a robust fourth quarter with strong cash flow driving a significant net debt reduction, while its Loop decarbonisation joint venture gains momentum with new contracts.

Lake Resources reports a significant 40% reduction in quarterly cash expenditures alongside a 10% increase in lithium resources at its flagship Kachi project, while advancing key development milestones and exploring strategic options.

FleetPartners delivered a resilient 3Q25 performance with 5% growth in key metrics despite operational challenges from a major system upgrade. A recent $400 million asset-backed securitisation deal also improved funding costs, positioning the company for growth in underpenetrated markets.

PointsBet has firmly dismissed Betr Entertainment’s unsolicited scrip takeover proposal, endorsing instead MIXI Australia’s superior all-cash offer. The board highlights significant risks and uncertainties tied to Betr’s bid while unanimously recommending shareholders accept MIXI’s $1.20 per share offer.

Paladin Energy outlines FY2026 operational ramp-up and financial guidance for its Langer Heinrich Mine, projecting increased uranium production and steady cost control ahead of full-scale operations in FY2027.

Firebrick Pharma has published positive Phase 3 clinical trial results for its Nasodine nasal spray, showing efficacy against the common cold, while reporting encouraging sales growth in Singapore and the US. However, a recent capital raise fell well short of targets, casting uncertainty over its expansion plans.

Generation Development Group reports a transformative FY25 with record Investment Bond sales and successful integration of Evidentia and Lonsec managed accounts, setting the stage for strong growth in FY26.